Pettyjohn, Wood & White, Inc Abbott Laboratories Transaction History

Pettyjohn, Wood & White, Inc

$557 Million
Q2 2025

A detailed history of Pettyjohn, Wood & White, Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Pettyjohn, Wood & White, Inc holds 58,571 shares of ABT stock, worth $7.67 Million. This represents 1.43% of its overall portfolio holdings.

Number of Shares

58,571

Previous 58,962 0.66%

Holding current value

$7.67 Million

Previous $7.82 Million 1.85%

% of portfolio

1.43%

Previous 1.5%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	SELL	$123.95 - $138.08 $48,464 - $53,989	-391 Reduced 0.66%	58,571 $7.97 Million
Q1 2025 May 08, 2025	SELL	$111.1 - $140.22 $299,414 - $377,892	-2,695 Reduced 4.37%	58,962 $7.82 Million
Q4 2024 Feb 05, 2025	BUY	$111.93 - $119.39 $59,322 - $63,276	530 Added 0.87%	61,657 $6.97 Million
Q3 2024 Nov 12, 2024	BUY	$100.07 - $118.13 $28,920 - $34,139	289 Added 0.48%	61,127 $6.97 Million
Q2 2024 Aug 14, 2024	SELL	$100.73 - $112.44 $52,983 - $59,143	-526 Reduced 0.86%	60,838 $6.32 Million
Q1 2024 May 08, 2024	BUY	$109.52 - $120.96 $82,797 - $91,445	756 Added 1.25%	61,364 $6.97 Million
Q4 2023 Feb 14, 2024	BUY	$90.19 - $110.4 $81,621 - $99,912	905 Added 1.52%	60,608 $6.67 Million
Q3 2023 Nov 14, 2023	BUY	$95.53 - $114.62 $302,065 - $362,428	3,162 Added 5.59%	59,703 $5.78 Million
Q2 2023 Aug 10, 2023	BUY	$100.78 - $112.29 $26,404 - $29,419	262 Added 0.47%	56,541 $6.16 Million
Q1 2023 Apr 25, 2023	BUY	$96.86 - $114.01 $58,794 - $69,204	607 Added 1.09%	56,279 $5.7 Million
Q4 2022 Feb 02, 2023	SELL	$95.06 - $111.52 $27,567 - $32,340	-290 Reduced 0.52%	55,672 $6.11 Million
Q3 2022 Oct 28, 2022	SELL	$96.76 - $112.03 $5,128 - $5,937	-53 Reduced 0.09%	55,962 $5.42 Million
Q2 2022 Aug 08, 2022	BUY	$102.07 - $123.37 $218,123 - $263,641	2,137 Added 3.97%	56,015 $6.09 Million
Q1 2022 Apr 22, 2022	SELL	$114.02 - $139.04 $66,473 - $81,060	-583 Reduced 1.07%	53,878 $6.38 Million
Q4 2021 Feb 04, 2022	SELL	$115.53 - $141.46 $99,933 - $122,362	-865 Reduced 1.56%	54,461 $7.67 Million
Q3 2021 Nov 08, 2021	BUY	$116.66 - $129.06 $94,844 - $104,925	813 Added 1.49%	55,326 $6.54 Million
Q2 2021 Aug 03, 2021	BUY	$105.79 - $124.53 $266,061 - $313,192	2,515 Added 4.84%	54,513 $6.32 Million
Q1 2021 May 10, 2021	BUY	$108.84 - $128.23 $88,269 - $103,994	811 Added 1.58%	51,998 $6.23 Million
Q4 2020 Feb 04, 2021	SELL	$105.0 - $114.42 $39,795 - $43,365	-379 Reduced 0.73%	51,187 $5.6 Million
Q3 2020 Oct 26, 2020	SELL	$91.64 - $111.29 $79,818 - $96,933	-871 Reduced 1.66%	51,566 $5.61 Million
Q2 2020 Aug 04, 2020	SELL	$76.57 - $98.0 $14,548 - $18,620	-190 Reduced 0.36%	52,437 $4.79 Million
Q1 2020 Apr 20, 2020	BUY	$62.82 - $91.86 $33,294 - $48,685	530 Added 1.02%	52,627 $4.15 Million
Q4 2019 Feb 11, 2020	SELL	$78.51 - $87.4 $59,510 - $66,249	-758 Reduced 1.43%	52,097 $4.53 Million
Q3 2019 Nov 04, 2019	SELL	$81.84 - $88.74 $131,844 - $142,960	-1,611 Reduced 2.96%	52,855 $4.42 Million
Q2 2019 Aug 02, 2019	BUY	$72.88 - $85.0 $12,316 - $14,365	169 Added 0.31%	54,466 $4.58 Million
Q1 2019 Apr 26, 2019	SELL	$66.22 - $80.06 $112,772 - $136,342	-1,703 Reduced 3.04%	54,297 $4.34 Million
Q4 2018 Feb 08, 2019	SELL	$65.56 - $74.27 $30,813 - $34,906	-470 Reduced 0.83%	56,000 $4.05 Million
Q3 2018 Nov 13, 2018	SELL	$60.81 - $73.36 $209,308 - $252,505	-3,442 Reduced 5.75%	56,470 $4.14 Million
Q2 2018 Aug 13, 2018	SELL	$57.57 - $63.54 $95,566 - $105,476	-1,660 Reduced 2.7%	59,912 $3.65 Million
Q1 2018 May 11, 2018	BUY	$56.27 - $63.62 $91,663 - $103,636	1,629 Added 2.72%	61,572 $3.69 Million
Q4 2017 Feb 13, 2018	SELL	$53.68 - $57.47 $289,335 - $309,763	-5,390 Reduced 8.25%	59,943 $3.42 Million
Q3 2017 Nov 13, 2017	BUY	$48.06 - $53.64 $3.14 Million - $3.5 Million	65,333	65,333 $3.49 Million

Others Institutions Holding ABT

# of Institutions

3,580

Shares Held

1.39B

Call Options Held

9.32M

Put Options Held

8.78M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $229B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pettyjohn, Wood & White, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Pettyjohn, Wood & White, Inc with notifications on news.

Account

Pettyjohn, Wood & White, Inc Abbott Laboratories Transaction History